UNKNOWNNA

Evaluation of a Clinical Transitional Program in Autism

Clinical trial without drug, randomized: Comparison of a specific and integrative clinical protocol for young adults with autism to usual treatment. It will include both low and high-functioning participants.

Sponsor

Corporacion Parc Tauli

Enrollment

102 participants

Sites

1 locations

Start Date

March 2017

Completion

March 2019

Autism Spectrum Disorder (ASD)Integrative interventional programmeAs usual

Enrollment & Timeline

UNKNOWN

Target enrollment (estimated)

Target N

102

participants

Sites

locations

Duration

2.1 years

total trial span

Rate

pts/month needed

Mar 2017Month 109 of 25Mar 2019

100% of trial timeline elapsed

At 1 sites, each site needs to enroll approximately 4.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Change in Quality of life.

Baseline, 24 months

The World Health Organization Quality of Life (WHOQOL). Self-administered scale, quantitative. Spanish version.

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

UNKNOWNNA

Evaluation of a Clinical Transitional Program in Autism

Sponsor

Corporacion Parc Tauli

Enrollment

102 participants

Sites

1 locations

Start Date

March 2017

Completion

March 2019

Autism Spectrum Disorder (ASD)Integrative interventional programmeAs usual

Enrollment & Timeline

UNKNOWN

Target enrollment (estimated)

Target N

102

participants

Sites

locations

Duration

2.1 years

total trial span

Rate

pts/month needed

Mar 2017Month 109 of 25Mar 2019

100% of trial timeline elapsed

At 1 sites, each site needs to enroll approximately 4.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Change in Quality of life.

Baseline, 24 months

The World Health Organization Quality of Life (WHOQOL). Self-administered scale, quantitative. Spanish version.

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

18 Years

Max Age

21 Years

Sex

all

Healthy Volunteers

View full criteria

Inclusion Criteria:

* ASD diagnosis
* Previous follow-up by child and adolescent psychiatry department at Corporació Sanitària Parc Taulí (CSPT)

Exclusion Criteria:

\- Living in a disabled residential setting

Evaluation of a Clinical Transitional Program in Autism

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Evaluation of a Clinical Transitional Program in Autism

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)